PROTEONIC UNVEILS EARLY ACCESS PROGRAM, ELEVATING VIRAL VECTOR TITERS WITH TRANSFORMATIVE LV-2G UNIC® TECHNOLOGY

Posted on by

LEIDEN, Netherlands, March 27, 2024 /PRNewswire/ — ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, is announcing the launch of its highly anticipated LV-2G UNic® Early Access Program. This program marks a significant…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.